In the T2D mice model, liraglutide showed an effect of alleviating steatosis (Zhang et al., 2021
Meanwhile, in January 1996 the first rodent study suggested that GLP-1 could be a central regulator of feeding behavior and satiety based on intracerebroventricular injection studies [4], but soon thereafter the results of other rodent studies using peripherally injected GLP-1 argued against an appetite effect [5]
While oral formulations offer non-invasive dosing, their low bioavailability and potential gastrointestinal side effects have remained major limitations
Many are simply tired of fighting biology that stopped responding the way it used to
These medications work by binding to GLP-1 receptors in the body, which increases insulin production in response to food intake and suppresses glucagon, a hormone that raises blood sugar
Instead, we are happy to cheer our patients on as they achieve a more healthy weight and maintain it after they have finished their course of medication